Stocks and Investing
Stocks and Investing
Tue, January 10, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Daina Graybosch Maintained (TSVT) at Buy with Decreased Target to $34 on, Jan 10th, 2023
Daina Graybosch of SVB Leerink, Maintained "2seventy bio, Inc." (TSVT) at Buy with Decreased Target from $41 to $34 on, Jan 10th, 2023.
Daina has made no other calls on TSVT in the last 4 months.
There are 2 other peers that have a rating on TSVT. Out of the 2 peers that are also analyzing TSVT, 0 agree with Daina's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Daina
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $29 on, Tuesday, November 8th, 2022
- Kelsey Goodwin of "Guggenheim" Initiated at Strong Buy and Held Target at $30 on, Monday, October 31st, 2022
Contributing Sources